
Terry Glassman
288 posts

Terry Glassman
@TerryGlassman
#Myeloma & PCL Patient ~ IMF Support Group Leader ~ Patient Coach ~ Advocate ~ Fighting the fight with my fellow MM peeps ~ Retired ICU/Cardiac Research RN




I co-lead this monthly group with @TerryGlassman and if you or someone you support has high-risk myeloma, we would be happy to have you join us! Reach out to HRMM@IMFsupport.org for more information! #MoreThanMyeloma #MyelomaActionMonth



Just in: Good news for the myeloma field. FDA approves teclistamab plus daratumumab (Tec-Dara) combination for myeloma for patients who have had at least one prior line of therapy. Note: Always use Tec-Dara with monthly IVIG. It’s not optional. That was fast! And this is unprecedented curve is why.









Exciting data for patients and the myeloma field #mmsm ➡️ MajesTEC-9: ~590 patients phase 3 RCT of Tec vs. PVd vs. Kd in patients with RRMM (1-3 prior lines)👇 ✅refractory to anti-CD38 monoclonal antibodies (85%) ✅ refractory to lenalidomide (79%) ➡️ PFS HR 0.29; 95% CI 0.23–0.38 ➡️OS HR 0.60; 95% CI 0.43–0.83 Great news following MajesTEC-3, teclistamab single agent can be a valuable option for patients at early relapse ➡️jnj.com/media-center/p…













